Your browser doesn't support javascript.
loading
C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer.
Liao, Li; Deng, Ling; Zhang, Yin-Ling; Yang, Shao-Ying; Andriani, Lisa; Hu, Shu-Yuan; Zhang, Fang-Lin; Shao, Zhi-Min; Li, Da-Qiang.
Affiliation
  • Liao L; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Deng L; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang YL; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yang SY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Andriani L; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu SY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhang FL; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shao ZM; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li DQ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
Clin Transl Med ; 13(11): e1480, 2023 11.
Article in En | MEDLINE | ID: mdl-38009308
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Animals / Humans Language: En Journal: Clin Transl Med Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Limits: Animals / Humans Language: En Journal: Clin Transl Med Year: 2023 Document type: Article Affiliation country: Country of publication: